Vaxxinity joins transcelerate research and development consortium

Cape canaveral, fla., march 21, 2023 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx), a u.s. company pioneering the development of a new class of immunotherapeutic vaccines, announced today that it has joined transcelerate biopharma, inc. (transcelerate) as the first emerging biotechnology organization of the trailblazing consortium that is accelerating and simplifying the research and development of innovative new therapies.
VAXX Ratings Summary
VAXX Quant Ranking